nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 29th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 11:28AM
|
Aug 29th, 2022 11:28AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 28th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 04:27AM
|
Aug 28th, 2022 04:27AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 27th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 03:47AM
|
Aug 27th, 2022 03:47AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 25th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 08:27AM
|
Aug 25th, 2022 08:27AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 23rd, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 10:20AM
|
Aug 23rd, 2022 10:20AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 21st, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 12:03PM
|
Aug 21st, 2022 12:03PM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 20th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 01:40PM
|
Aug 20th, 2022 01:40PM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 19th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 12:04PM
|
Aug 19th, 2022 12:04PM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 18th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 03:47AM
|
Aug 18th, 2022 03:47AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|
nasdaq:atrc
|
https://www.indeed.com/cmp/atricure,-inc.
|
Aug 17th, 2022 12:00AM
|
Open
|
AtriCure, Inc.
|
|
Manufacturing
|
As a leading provider of innovative technologies for the treatment of Atrial Fibrillation (Afib) and related conditions, electrophysiologists and cardiothoracic surgeons around the globe count on AtriCure to deliver best-in-class solutions that can treat even the most complex cases. Our Isolator® Synergy™ Ablation System is the first and only medical device approved by the FDA for the treatment of long standing persistent Afib, our AtriClip Left Atrial Appendage (LAA) Exclusion System products are the most widely used LAA management devices worldwide, and we are expanding into pain management therapies. We invest in innovation, clinical science, and education to focus on improving lives for our patients worldwide.
As AtriCure’s product portfolio grows, so does its team. These hard-working, dedicated individuals are carefully selected based on expertise and reputation within the medical device industry. Team members have joined AtriCure to fulfill not only its mission, but also to realize their own. Today, over 750 employees work for AtriCure in a variety of capacities.
If you are interested in a career with a fast growing, innovative company, check out our opportunities and apply today!
|
RRv1_100M_500M
|
7555 Innovation Way Mason, OH 45040
|
|
|
|
3.30
|
72.0
|
69.0
|
78.0
|
62.0
|
67.0
|
67.0
|
69.0
|
72.0
|
64.0
|
72.0
|
|
72.0
|
72.0
|
21.0
|
37.00
|
37.00
|
3.20
|
3.60
|
2.80
|
2.90
|
3.10
|
11.00
|
About a day or two
|
12.00
|
MEDIUM
|
12.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 09:26AM
|
Aug 17th, 2022 09:26AM
|
AtriCure
|
Health Care
|
Health Care Equipment & Services
|